Quote:
Originally Posted by mhays
Metrics are good, but the concept shouldn't surprise anybody.
Even with some patients coming from elsewhere, and some funding coming from elsewhere, much of the healthcare market is about serving the local population. When the economy is down, people put off some things, or skip healthcare entirely especially if they're not insured.
Houston is presumably one of the cities that gets a decent amount of incoming patients from elsewhere, along with Baltimore, Cleveland, and a handful of others. But its federal NIH funding is below par. Neither is on the scale of several million locals averaging thousands per year, which the economy impacts pretty directly.
|
Not sure how they are related? Houston excels at care and treatment and is average to below average at research and commercialization, save cancer research.
Essentially after 15 years over adding ~100,000ppl /year to the metro growth is slowing. Many predicted that oil would rise to more profitable levels late 2016/2017 but global demand (in general) is being revisited downwards.